NeoImmuneTech, Inc. (KOSDAQ:950220)

South Korea flag South Korea · Delayed Price · Currency is KRW
766.00
+22.00 (2.96%)
Oct 10, 2025, 3:30 PM KST
2.96%
Market Cap75.73B
Revenue (ttm)208.50M
Net Income (ttm)-34.70B
Shares Out98.87M
EPS (ttm)-350.96
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,452,825
Average Volume1,815,007
Open746.00
Previous Close744.00
Day's Range723.00 - 770.00
52-Week Range713.00 - 1,881.00
Beta0.61
RSI35.99
Earnings DateNov 14, 2025

About NeoImmuneTech

NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 52
Stock Exchange KOSDAQ
Ticker Symbol 950220
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.